Joel S. Raichlen

7.3k total citations · 3 hit papers
68 papers, 5.4k citations indexed

About

Joel S. Raichlen is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Joel S. Raichlen has authored 68 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 32 papers in Cardiology and Cardiovascular Medicine and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Joel S. Raichlen's work include Lipoproteins and Cardiovascular Health (30 papers), Cardiac Imaging and Diagnostics (19 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers). Joel S. Raichlen is often cited by papers focused on Lipoproteins and Cardiovascular Health (30 papers), Cardiac Imaging and Diagnostics (19 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers). Joel S. Raichlen collaborates with scholars based in United States, Netherlands and United Kingdom. Joel S. Raichlen's co-authors include Christie M. Ballantyne, Stephen J. Nicholls, Steven E. Nissen, Peter Libby, Valerie A. Cain, Kathy Wolski, Raimund Erbel, Jean‐Claude Tardif, Michiel L. Bots and Mike K. Palmer and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Joel S. Raichlen

64 papers receiving 5.2k citations

Hit Papers

Effect of Very High-Inten... 2006 2026 2012 2019 2006 2011 2007 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel S. Raichlen United States 30 3.3k 2.0k 1.6k 1.0k 947 68 5.4k
Albert V.G. Bruschke Netherlands 41 3.2k 1.0× 3.1k 1.6× 2.0k 1.2× 778 0.8× 1.1k 1.2× 131 6.6k
Pasquale Perrone Filardi Italy 47 2.1k 0.6× 4.8k 2.4× 2.0k 1.2× 908 0.9× 1.4k 1.5× 311 7.9k
B. Greg Brown United States 44 5.2k 1.6× 3.7k 1.9× 2.8k 1.7× 1.2k 1.2× 2.2k 2.3× 100 8.8k
Atsushi Hirayama Japan 39 2.6k 0.8× 3.4k 1.7× 1.6k 0.9× 907 0.9× 503 0.5× 354 6.0k
Katsumi Miyauchi Japan 38 2.8k 0.9× 2.9k 1.4× 1.1k 0.7× 653 0.6× 960 1.0× 303 6.2k
Bariş Gencer Switzerland 32 3.7k 1.1× 6.5k 3.3× 2.2k 1.4× 506 0.5× 1.3k 1.4× 188 9.9k
Leslie Cho United States 38 2.8k 0.8× 2.3k 1.1× 622 0.4× 500 0.5× 691 0.7× 178 5.4k
Christopher T. Sibley United States 35 1.5k 0.5× 3.1k 1.6× 2.6k 1.6× 618 0.6× 880 0.9× 83 5.8k
Jacek Kubica Poland 35 2.6k 0.8× 3.1k 1.5× 658 0.4× 406 0.4× 569 0.6× 319 5.1k
James C. Blankenship United States 35 6.4k 1.9× 7.2k 3.6× 3.4k 2.1× 1.6k 1.6× 845 0.9× 172 10.6k

Countries citing papers authored by Joel S. Raichlen

Since Specialization
Citations

This map shows the geographic impact of Joel S. Raichlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel S. Raichlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel S. Raichlen more than expected).

Fields of papers citing papers by Joel S. Raichlen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel S. Raichlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel S. Raichlen. The network helps show where Joel S. Raichlen may publish in the future.

Co-authorship network of co-authors of Joel S. Raichlen

This figure shows the co-authorship network connecting the top 25 collaborators of Joel S. Raichlen. A scholar is included among the top collaborators of Joel S. Raichlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel S. Raichlen. Joel S. Raichlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yanan, Crystel M. Gijsberts, Arjan H. Schoneveld, et al.. (2018). LDL extracellular vesicle coagulation protein levels change after initiation of statin therapy. Findings from the METEOR trial. International Journal of Cardiology. 271. 247–253. 22 indexed citations
2.
Puri, Rishi, Steven E. Nissen, Mingyuan Shao, et al.. (2014). Sex-Related Differences of Coronary Atherosclerosis Regression Following Maximally Intensive Statin Therapy. JACC. Cardiovascular imaging. 7(10). 1013–1022. 41 indexed citations
3.
Langslet, Gisle, Marjet J.A.M. Braamskamp, Brian W. McCrindle, et al.. (2014). EFFECT OF ROSUVASTATIN THERAPY ON ARTERIAL WALL CHANGES IN CHILDREN AND ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE CHARON STUDY. Journal of the American College of Cardiology. 63(12). A1379–A1379. 2 indexed citations
4.
Langslet, Gisle, Marjet J.A.M. Braamskamp, Brian W. McCrindle, et al.. (2014). EFFICACY AND SAFETY OF ROSUVASTATIN THERAPY FOR CHILDREN AND ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE CHARON STUDY. Journal of the American College of Cardiology. 63(12). A1288–A1288.
5.
Puri, Rishi, Steven E. Nissen, Christie M. Ballantyne, et al.. (2013). Factors underlying regression of coronary atheroma with potent statin therapy. European Heart Journal. 34(24). 1818–1825. 59 indexed citations
6.
Lind, Lars, Sanne A. E. Peters, Hester M. den Ruijter, et al.. (2012). Effect of Rosuvastatin on the Echolucency of the Common Carotid Intima-Media in Low-Risk Individuals: The METEOR Trial. Journal of the American Society of Echocardiography. 25(10). 1120–1127.e1. 19 indexed citations
7.
Madden, Sean, Joel S. Raichlen, & James E. Muller. (2012). SPECTROSCOPIC DETECTION OF FIBROUS CAP THICKNESS OVERLYING LIPID CORE CORONARY PLAQUES WITH A CATHETER-BASED NEAR-INFRARED SPECTROSCOPY SYSTEM. Journal of the American College of Cardiology. 59(13). E308–E308. 3 indexed citations
8.
Pitt, Bertram, Joseph Loscalzo, John T. Monyak, Elinor Miller, & Joel S. Raichlen. (2012). Comparison of Lipid-Modifying Efficacy of Rosuvastatin Versus Atorvastatin in Patients With Acute Coronary Syndrome (from the LUNAR Study). The American Journal of Cardiology. 109(9). 1239–1246. 50 indexed citations
9.
Nicholls, Stephen J., Christie M. Ballantyne, P.J. Barter, et al.. (2012). REGRESSION OF CORONARY ATHEROMA VOLUME IN PATIENTS RECEIVING HIGH DOSE STATIN THERAPY: ANALYSIS OF THE SATURN STUDY. Journal of the American College of Cardiology. 59(13). E1502–E1502.
10.
Peters, Sanne A. E., Mike K. Palmer, Diederick E. Grobbee, et al.. (2011). Effect of number of ultrasound examinations on the assessment of carotid intima–media thickness changes over time: the example of the METEOR study. Journal of Hypertension. 29(6). 1145–1154. 7 indexed citations
11.
Ballantyne, Christie M., Joel S. Raichlen, Stephen J. Nicholls, et al.. (2008). Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography. Circulation. 117(19). 2458–2466. 158 indexed citations
12.
Underhill, Hunter R., Chun Yuan, Xue-Qiao Zhao, et al.. (2008). Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high-resolution magnetic resonance imaging trial. American Heart Journal. 155(3). 584.e1–584.e8. 201 indexed citations
13.
Oikawa, Minako, Chun Yuan, Hunter R. Underhill, et al.. (2007). Abstract 1912: Time Course of Change in Plaque Composition Associated with Rosuvastatin Therapy as Assessed by High-Resolution Magnetic Resonance Imaging. Circulation. 116.
14.
Bots, Michiel L., Joel S. Raichlen, Gregory W. Evans, et al.. (2007). Abstract 194: Rosuvastatin Reduces Progression of Carotid Atherosclerosis within 12 Months of Treatment: The METEOR Trial. Circulation. 116(suppl_16). 2 indexed citations
15.
Ballantyne, Christie M., Marcelo Chiara Bertolami, Evan A. Stein, et al.. (2006). Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II. American Heart Journal. 151(5). 975.e1–975.e9. 87 indexed citations
16.
17.
Liebson, Philip R., et al.. (2002). Effect of contrast enhancement on measurement of carotid artery intimal medial thickness. Journal of the American College of Cardiology. 39. 219–219. 2 indexed citations
18.
Crouse, Linda J., Joseph Kisslo, Arthur J. Labovitz, et al.. (1993). Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the phase III albunex multicenter trial. Journal of the American College of Cardiology. 22(5). 1494–1500. 186 indexed citations
19.
Raichlen, Joel S., et al.. (1986). Dynamic three-dimensional reconstruction of the left ventricle from two-dimensional echocardiograms. Journal of the American College of Cardiology. 8(2). 364–370. 95 indexed citations
20.
Raichlen, Joel S., Jonathan M. Links, & Philip R. Reid. (1985). Effect of electrical activation site on left ventricular performance in ventricular tachycardia patients with coronary heart disease. The American Journal of Cardiology. 55(1). 84–88. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026